Cierre Percutáneo de Orejuela izquierda con dispositivo LAmbre

  1. Rodrigo Muñoz
  2. Ignacio Cruz González
  3. Marcelo Gómez Silva
  4. Javier Rodriguez Collado
  5. Jean Nuñez
Revista:
Revista chilena de cardiología

ISSN: 0718-8560

Año de publicación: 2020

Volumen: 39

Número: 2

Páginas: 154-158

Tipo: Artículo

DOI: 10.4067/S0718-85602020000200154 DIALNET GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Revista chilena de cardiología

Resumen

Atrial fibrillation (AF) is an increasing health care problem associated with thromboembolic risk about 5% per year, with high mortality and morbidity when associated to stroke. Oral anticoagulants (OAC) are the treatment of choice for preventing ischemic stroke in patients with nonvalvular atrial fibrillation (NVAF). However, these drugs are associated with an increased risk of serious complications such an intracranial hemorrhage (ICH). In this context percutaneous closure of the left atrial appendage (LAA) is an effective therapeutic alternative to OACs, with an increasing success rate. Novel devices might allow or facilitate the procedure in some anatomically and technically complicated cases. Two patients with a complex morphology of the LAA, in which the LAmbre (Lifetech Scientific [Shenzhen] Co. Ltd.) device was implanted with good technical and clinical results are presented.

Referencias bibliográficas

  • JANUARY, CT,WANN, LS,ALPERT, JS,CALKINS, H,CIGARROA, JE,CLEVELAND, JC. (2014). 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 130. 2071
  • GRYSIEWICZ, R,GORELICK, PB. (2014). Incidence, mortality, and risk factors for oral anticoagulant associated intracranial hemorrhage in patients with atrial fibrillation. J Stroke Cerebrovasc Dis. 23. 2479
  • TZIKAS, A,GAFOOR, S,MEERKIN, D. (2016). Left atrial appendage occlusion with the Amplatzer Amulet device: an expert consensus step-by-step approach. EuroIntervention. 11. 1512
  • CRUZ-GONZÁLEZ, I,RAMA-MERCHAN, JC,MARTÍNEZ-PERALTA, S,LÓPEZ-MESONERO, L,RODRÍGUEZ-COLLADO, J,SÁNCHEZ, PL. (2017). Eficacia y seguridad del cierre percutáneo de orejuela izquierda en pacientes con hemorragia intracraneal. Rev Esp Cardiol. 70. 58-60
  • BOERSMA, LV,SCHMIDT, B,BETTS, TR. (2016). Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry. Eur Heart J. 37. 2465
  • CRUZ-GONZÁLEZ, I,ARZAMENDI, D,RAMA-MERCHAN, JC,PIÑA-GONZÁLEZ, P,SÁNCHEZ, PL,SERRA, A. (2015). Left atrial appendage occlusion with the new AmuletTM device: feasibility, safety and short-term efficacy. Rev Esp Cardiol. 68. 724
  • LAM, YY. (2013). A new left atrial appendage occluder (Lifetech LAmbre Device) for stroke prevention in atrial fibrillation. Cardiovasc Revasc Med. 14. 134
  • LAM, YY,YAN, BP,DOSHI, SK. (2013). Preclinical evaluation of a new left atrial appendage occluder (Lifetech LAmbreTM device) in a canine model. Int J Cardiol. 168. 3996-4001
Fuente de los datos: Dialnet